PharmacologyLifestyle scienceEvidence Tier I

Collagen supplements: which forms are absorbed and which are not

Not all collagen is equal. The difference between a product that works and one that doesn't comes down to molecular weight, peptide composition, and what happens in the gut before any of it reaches your skin.

Dr. Hana Okafor, MSc
May 19, 2026
3 min read

The collagen supplement market is worth several billion dollars annually, and the majority of products on it are probably inert. That is a strong claim, so it requires a careful explanation — because some collagen products do work, and the difference between the ones that do and the ones that don't is not obvious from the label.

Why whole collagen doesn't work

Collagen is a large structural protein — a triple helix of three polypeptide chains, each roughly 1,400 amino acids long. When you swallow it, your digestive system does what it does to all proteins: it breaks it down into amino acids and small peptides. The collagen triple helix does not survive digestion intact. This means that eating whole collagen — from bone broth, for example — delivers amino acids (primarily glycine, proline, and hydroxyproline) but not intact collagen. The amino acids are useful for general protein synthesis, but there is no evidence that they specifically stimulate dermal collagen production at the doses found in typical servings.

What hydrolysed collagen actually delivers

Hydrolysed collagen (collagen hydrolysate) is different. In this form, the collagen has been enzymatically pre-digested into short peptides — typically 2 to 10 amino acids long — before you consume it. These peptides survive the gut in meaningful concentrations. Specifically, two peptides — glycine-proline-hydroxyproline (GPH) and proline-hydroxyproline (PH) — have been detected in human blood after oral collagen hydrolysate ingestion. These are not found in significant concentrations after eating whole protein. Their presence in circulation is the mechanistic basis for the clinical effects observed in RCTs.

The proposed mechanism: GPH and PH peptides reach dermal fibroblasts, where they act as signalling molecules — stimulating the synthesis of new procollagen type I, elastin, and hyaluronic acid. The fibroblast interprets the presence of these collagen-derived peptides as a signal that collagen has been degraded and needs replacing. Whether this interpretation is entirely correct is still debated, but the downstream effects in controlled trials are real.

The Verisol® evidence

The most replicated evidence is for Verisol®, a specific bioactive collagen peptide (BCP) formulation developed by Gelita AG. In a 2014 double-blind, placebo-controlled trial (Proksch et al., n=114), women aged 45–65 who took 2.5 g of Verisol® daily for 8 weeks showed a 20% reduction in eye wrinkle volume, a 65% increase in procollagen type I content, and an 18% increase in elastin content compared to placebo. A 2013 trial by the same group (n=69) showed statistically significant improvement in skin elasticity at both 2.5 g and 5.0 g doses.

20% reduction in eye wrinkle volume. 65% increase in procollagen type I. 18% increase in elastin. These effects persisted for at least 4 weeks after supplementation ceased.

Proksch E et al., Skin Pharmacol Physiol, 2014

A 2024 trial (Lu et al., n=70) using a fish collagen tripeptide formulation showed a 39% increase in skin hydration, a 33% decrease in transepidermal water loss, a 25% increase in skin elasticity, and a 22% increase in dermal collagen content after 8 weeks. The effect sizes are consistent with the Verisol® literature, suggesting the mechanism generalises across specific hydrolysate products — though the Verisol® trials remain the most rigorously conducted.

What to look for on a label

  • Molecular weight: effective hydrolysates typically have an average molecular weight of 2,000–5,000 Da. Products that do not disclose molecular weight are a red flag.
  • Dose: the Verisol® trials used 2.5 g/day. Most effective trials fall in the 2.5–10 g/day range. Products dosed below 1 g/day are unlikely to replicate these effects.
  • Source: marine (fish) and bovine collagen hydrolysates have both shown efficacy. Porcine and chicken sources have less clinical data but are mechanistically plausible.
  • Additives: several trials combined collagen with vitamin C, which is a cofactor for collagen synthesis. This combination is rational; vitamin C alone at adequate doses also supports collagen production.
  • Generic 'collagen protein': products marketed as collagen protein powders for muscle building are not the same as specific bioactive collagen peptides. The amino acid profile overlaps; the peptide composition does not.

Vitaei verdict

Hydrolysed collagen peptides at 2.5–10 g/day have Tier I evidence for skin elasticity and wrinkle reduction. The mechanism is understood. The effect size is modest but real and durable. Whole collagen (bone broth, collagen protein powder) has no specific skin evidence beyond general protein intake. The difference is the peptide composition, not the marketing.